Schedule 13G ownership disclosure

Entrada Therapeutics Inc

Security class unavailable · CUSIP: 29384C108

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,010,351
Percent of class
3.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000846087-23-000103
Form type
SC 13G/A
Filer
Entrada Therapeutics, Inc.
CIK
CIK 1689375
Filed
Feb 06, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub